Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Optimists likely call it a consolidation phase, but the reality is that the market appears to be having second thoughts about the QE3-inspired gains. The gains started in the summer and pushed stocks to their highest level after the announcement.
The market pause of the last few trading sessions may just be a sign of tentativeness and nervousness ahead of next week’s key economic data and the start of the third quarter reporting season. But the tentativeness is completely justified. The return today of Spain and Eurozone-centric concerns will add to the nervousness.
I have been skeptical of the sustainability of Fed-inspired gains for awhile and continue to believe that Bernanke’s open-ended bond purchase program is largely irrelevant to the broader issues facing the U.S. economy. Lack of economic growth, both in the U.S. as well as worldwide, is steadily emerging as a far bigger drag on corporate profitability than many in the market realize at this stage. We have seen this show up in earnings projections for the third quarter, which are expected to be down 3.4% from the same period last year.
But expectations remain high for the fourth quarter and beyond in the hope that the economic growth issues in the U.S. and China will prove to be temporary. It is useful to be somewhat skeptical of that view at this stage and view the recent profit warnings from companies like FedEx (FDX - Analyst Report), Intel (INTC - Analyst Report) and Norfolk Southern (NSC - Analyst Report) as a sign of things to come.
My sense is that the third quarter reporting season will provide this market a reality check, helping bring down earnings and overall growth expectations for the out quarters. This may not trigger a precipitous market sell-off, but it will most likely cause the market to give back some, if not all, of its recent gains.
Get the full Analyst Report on FDX - FREE
Get the full Analyst Report on INTC - FREE
Get the full Analyst Report on NSC - FREE